Myriad Genetics | MYGN - Gross Profit On Sales

Stock Price
4.75
Daily Change
0.11 2.37%
Monthly
10.72%
Yearly
-52.07%
Q1 Forecast
4.52

Myriad Genetics reported $146.8M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Agilent USD 946M 44M Dec/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Bio-Rad Laboratories USD 343.4M 1.9M Sep/2025
Bruker USD 449.2M 69.8M Dec/2025
Danaher USD 3.97B 443M Dec/2025
Exact Sciences USD 583.93M 21.48M Sep/2025
Hologic USD 586.4M 2.9M Dec/2025
Illumina USD 759M 26M Dec/2025
J&J USD 16.6B 118M Dec/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 146.8M 3M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Pacific Biosciences Of California USD 15.74M 601K Dec/2025
Quest Diagnostics USD 873M 37M Dec/2025
Quidel USD 274.8M 1.01B Dec/2025
Repligen USD 103.83M 3.32M Dec/2025
Revvity USD 421.66M 47.06M Dec/2025
Standard Biotools USD 11.38M 1.9M Dec/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Veracyte USD 101.97M 10.69M Dec/2025
Waters USD 557.42M 97.44M Dec/2025